By Cara Murez
HealthDay Reporter
MONDAY, Jan. 3, 2022 (HealthDay News) — Here’s a lesson many might have already discovered over the previous weekend: Don’t rely on ginseng, probiotics or some other so-called hangover cures.
No proof suggests hangover cures work, in line with British scientists who studied practically two dozen trials of those remedy merchandise. Their evaluation was printed Dec. 31 within the journal Addiction.
“Our study has found that evidence on these hangover remedies is of very low quality and there is a need to provide more rigorous assessment,” mentioned lead writer Dr. Emmert Roberts, a medical analysis fellow at King’s College London.
His prescription: “For now, the surest method of stopping hangover signs is to abstain from alcohol or drink moderately,” Roberts mentioned in a journal information launch.
He and his colleagues reviewed 21 managed randomized trials of clove extract, purple ginseng, Korean pear juice, prickly pear, artichoke extract and different potential cures.
Some of the research did present statistically vital enhancements in hangover signs. But researchers mentioned the standard of the proof was low, normally due to limitations in research strategies or imprecise measures.
The reviewed research usually mentioned little concerning the nature and timing of the alcohol problem and had appreciable variations within the kinds of alcohol given or whether or not they got with meals. Eight research solely included males.
No two research reported on the identical hangover treatment. None of the outcomes had been independently replicated.
Common painkillers, together with acetaminophen and aspirin haven’t been evaluated in managed hangover trials, in line with the researchers.
They concluded that future research ought to be extra rigorous of their strategies, utilizing validated scales to evaluate signs, and embrace each women and men.
More info
The National Institute on Alcohol Abuse and Alcoholism has extra on alcohol’s results on the physique.
SOURCE: Addiction, information launch, Dec. 31, 2021